Suxamethonium myalgia: an ethnic comparison with and without pancuronium pretreatment

Area of Science:

• Anesthesiology
• Pharmacology
• Clinical Trials

Background:

• Post-suxamethonium myalgia is a common complication.
• Pancuronium is a neuromuscular blocking agent used to mitigate this side effect.
• Ethnic variations in drug response are increasingly recognized.

Purpose of the Study:

• To determine the incidence of myalgia after suxamethonium in male dental patients of diverse ethnicities.
• To evaluate the efficacy of pancuronium pretreatment in reducing post-suxamethonium myalgia.
• To assess the influence of ethnicity on recovery from neuromuscular blockade and anesthesia.

Main Methods:

• A randomized, double-blind study involving 200 fit military male dental patients.
• Patients received either pancuronium (1 mg) or saline pretreatment before suxamethonium administration.
• Data on myalgia incidence, recovery of spontaneous ventilation, and neuromuscular block were collected and analyzed based on ethnicity (European, Chinese, Nepalese).

Main Results:

• Pancuronium pretreatment reduced the overall incidence of myalgia by approximately 50%, though not statistically significant across ethnic groups.
• European patients showed quicker recovery of spontaneous ventilation after suxamethonium compared to Asian patients (p < 0.05).
• Pancuronium pretreatment delayed recovery from neuromuscular blockade and spontaneous ventilation independently of ethnicity (p < 0.05).

Conclusions:

• Ethnicity impacts recovery from suxamethonium and general anesthesia.
• Pancuronium pretreatment offers a potential, though not statistically significant, reduction in myalgia incidence across ethnic groups.
• The observed ethnic differences in recovery were not clinically relevant to myalgia incidence in this cohort.